Prediction nomogram development and validation for postoperative radiotherapy in the management of oral squamous cell carcinoma
File version
Author(s)
David, Michael
Clark, Jonathan RR
Low, Tsu-Hui Hubert
Batstone, Martin DD
Griffith University Author(s)
Primary Supervisor
Other Supervisors
Editor(s)
Date
Size
File type(s)
Location
License
Abstract
Background: Predictive nomograms are useful tools to guide clinicians in estimating disease course. Oral squamous cell carcinoma (OSCC) patients would benefit from an interactive prediction calculator that defines their levels of survival-risk specific to their tumors to guide the use of postoperative radiotherapy (PORT). Methods: Patients with OSCC surgically treated with curative intent at four Head and Neck Cancer Centres were recruited retrospectively for development and validation of nomograms. Predictor variables include PORT, age, T and N classification, surgical margins, perineural invasion, and lymphovascular invasion. Outcomes were disease-free, disease-specific, and overall survivals over 5 years. Results: 1296 patients with OSCC were in training cohort for nomogram analysis. Algorithms were developed to show relative benefit of PORT in survivals for higher-risk patients. External validation on 1212 patients found the nomogram to be robust with favorable discrimination and calibration. Conclusion: The proposed calculator can assist clinicians and patients in the decision-making process for PORT.
Journal Title
Head & Neck
Conference Title
Book Title
Edition
Volume
45
Issue
6
Thesis Type
Degree Program
School
Publisher link
Patent number
Funder(s)
Grant identifier(s)
Rights Statement
Rights Statement
Item Access Status
Note
Access the data
Related item(s)
Subject
Oncology and carcinogenesis
Oral medicine and pathology
Clinical sciences
Dentistry
Science & Technology
Life Sciences & Biomedicine
Otorhinolaryngology
Surgery
nomograms
Persistent link to this record
Citation
Liu, TPJ; David, M; Clark, JRR; Low, T-HH; Batstone, MDD, Prediction nomogram development and validation for postoperative radiotherapy in the management of oral squamous cell carcinoma, Head & Neck, 2023, 45 (6), pp. 1503-1510